Improvements in Asthma Quality of Life Questionnaire (AQLQ) Domains with Reslizumab in Patients with Inadequately Controlled Asthma and Elevated Blood Eosinophils

被引：2

作者：

Maspero, Jorge ^{[1
]}

Jacobs, Joshua ^{[2
]}

Garin, Margaret ^{[3
]}

机构：

[1] Fdn Cidea, Allergy & Resp Res Unit, Buenos Aires, Argentina

[2] Allergy & Asthma Clin Res Inc, Walnut Creek, CA USA

[3] Teva Pharmaceut, Pittsburgh, PA USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2016年 / 137卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2015.12.047

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：AB15 / AB15

页数：1

共 50 条

[1] Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils
Brusselle, Guy
Germinaro, Matthew
Weiss, Sivan
Zangrilli, James
[J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2017, 43 : 39 - 45
[2] Improvements In Individual Asthma Control Questionnaire (ACQ-5) Questions With Reslizumab In Patients With Inadequately Controlled Asthma and Elevated Blood Eosinophils: Pooled Analysis of Two Phase 3 Trials
Korenblat, Phillip E.
McDonald, Mirna
Garin, Margaret
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB17 - AB17
[3] Efficacy of Reslizumab in Asthma Patients with Aspirin Sensitivity and Elevated Blood Eosinophils
Katial, Rohit
Hoyte, Flavia
Germinaro, Matthew
McDonald, Mirna
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB8 - AB8
[4] Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects
Maspero, Jorge
[J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2017, 11 (08) : 311 - 325
[5] REDUCTION IN EXACERBATIONS WITH RESLIZUMAB IN KOREAN PATIENTS WITH ASTHMA AND ELEVATED BLOOD EOSINOPHILS
Park, Jung-Won
Cho, Sang Heon
Mcdonald, Mirna
Garin, Margaret
[J]. RESPIROLOGY, 2017, 22 : 169 - 169
[6] Intravenous (IV) reslizumab improves asthma control, symptoms, and quality of life in patients with historically elevated blood eosinophils
Chanez, Pascal
Adir, Yochai
Castro, Mario
Pahus, Laurie
Mcdonald, Mirna
Hickey, Lisa
Garin, Margaret
[J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[7] IMPROVEMENTS WITH RESLIZUMAB TREATMENT IN PATIENT-REPORTED SLEEP QUALITY IN PATIENTS WITH INADEQUATELY CONTROLLED EOSINOPHILIC ASTHMA
Jacobs, J.
Hickey, L.
Vanlandingham, R.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S43 - S44
[8] Reslizumab (RES) in patients (pts) with inadequately controlled asthma and elevated blood eosinophils (EOS): Analysis of two phase 3, placebo-controlled trials
Virchow, Johann Christian
Zangrilli, James
Weiss, Sivan
Korn, Stephanie
[J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[9] Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels A Randomized Phase 3 Study
Bjermer, Leif
Lemiere, Catherine
Maspero, Jorge
Weiss, Sivan
Zangrilli, James
Germinaro, Matthew
[J]. CHEST, 2016, 150 (04) : 789 - 798
[10] Reslizumab for Treating Asthma with Elevated Blood Eosinophils Inadequately Controlled by Inhaled Corticosteroids: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Keith Cooper
Geoff Frampton
Petra Harris
Micah Rose
Maria Chorozoglou
Karen Pickett
[J]. PharmacoEconomics, 2018, 36 : 545 - 553

← 1 2 3 4 5 →